Search results for "LED"

showing 10 items of 8768 documents

Effectiveness of Dry Needling in the Management of Spasticity in Patients Post Stroke.

2020

Abstract Objective: To determine the effectiveness of the dry needling technique (DNT) in the treatment of spasticity for individuals with stroke. Design: We reviewed the Embase, Pubmed/MEDLINE, Web of Science and Cochrane Central Register of Controlled Trials (CENTRAL) databases. We also performed a manual search of the references that are included in the selected articles. Studies included were: i) randomized clinical trials (RCTs); ii) involving patients with a diagnosis of stroke; and iii) using DNT alone or in a multimodal treatment. Muscular spasticity was the primary outcome of the study. The additional outcomes included were: pressure pain sensitivity, range of motion and perception…

AdultMalemedicine.medical_specialtyBlindingMEDLINElaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawMedicineHumansSpasticityStrokeAgedRandomized Controlled Trials as TopicDry needlingbusiness.industryRehabilitationMiddle Agedmedicine.diseaseStrokeTreatment OutcomeSample size determinationMuscle SpasticityDry NeedlingPhysical therapySurgeryFemaleNeurology (clinical)medicine.symptomCardiology and Cardiovascular MedicinebusinessRange of motion030217 neurology & neurosurgeryJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.

2013

The main objective was to compare the mean change in augmentation index of hypertensive patients treated with nebivolol or atenolol.Multicenter, double-blind randomized study conducted in six Spanish centers. We enrolled outpatients between the ages of 40 and 65 years with mild or moderate essential hypertension (systolic blood pressure, SBP ≥ 140 mmHg to ≤ 179 mmHg and diastolic blood pressure, DBP ≥ 90 mmHg to ≤ 109 mmHg after a 2-week run-in placebo period). Patients received nebivolol 5 mg or atenolol 50 mg once daily. At week 3, atenolol could be titrated up to 100 mg qd for non-responders. Additionally, patients not achieving normal blood pressure after 6 weeks could be treated with 2…

AdultMalemedicine.medical_specialtyBlood PressureEssential hypertensionlaw.inventionNebivololHydrochlorothiazideRandomized controlled trialDouble-Blind MethodlawInternal medicineInternal MedicinemedicineHumansBenzopyransAntihypertensive AgentsAgedbusiness.industryGeneral MedicineMiddle AgedAtenololmedicine.diseaseNebivololPulse pressureBlood pressureAtenololEthanolaminesAnesthesiaHypertensionCardiologyAortic pressureFemaleEssential HypertensionCardiology and Cardiovascular Medicinebusinessmedicine.drugBlood pressure
researchProduct

Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of human periodontal bony defects--a randomized controlled clinical tria…

2008

The aim of this study was to compare the clinical outcome of intrabony periodontal defects following treatment with a novel nanocrystalline hydroxyapatite (NHA) paste to open flap debridement.Twenty-eight subjects, each displaying one intrabony defect with probing depth (PD)or =6 mm and radiographic evidence of an intraosseous componentor =3 mm participated in the present study. Subjects were allocated randomly to treatment with NHA paste (test group) or open flap debridement (control group). At baseline and at 6 months after surgery, the following clinical parameters were recorded by a masked examiner: plaque index, gingival index, PD, clinical attachment level (CAL), and gingival recessio…

AdultMalemedicine.medical_specialtyBone Regenerationmedicine.medical_treatmentRadiographyAlveolar Bone LossDentistryStatistics Nonparametriclaw.inventionRandomized controlled triallawmedicineHumansBone regenerationPeriodontitisAgedPeriodontitisbusiness.industryOpen flap debridementMiddle Agedmedicine.diseaseChronic periodontitisSurgeryClinical trialDurapatiteTreatment OutcomeDebridementDebridement (dental)Bone SubstitutesPeriodonticsNanoparticlesFemalePeriodontal IndexbusinessJournal of periodontology
researchProduct

Brain Function and Upper Limb Outcome in Stroke: A Cross-Sectional fMRI Study

2015

Objective The nature of changes in brain activation related to good recovery of arm function after stroke is still unclear. While the notion that this is a reflection of neuronal plasticity has gained much support, confounding by compensatory strategies cannot be ruled out. We address this issue by comparing brain activity in recovered patients 6 months after stroke with healthy controls. Methods We included 20 patients with upper limb paresis due to ischemic stroke and 15 controls. We measured brain activation during a finger flexion-extension task with functional MRI, and the relationship between brain activation and hand function. Patients exhibited various levels of recovery, but all we…

AdultMalemedicine.medical_specialtyBrain activity and meditationlcsh:MedicineElectromyographyResearch SupportFunctional LateralityBrain IschemiaUpper ExtremityBrain ischemiaPhysical medicine and rehabilitationSDG 3 - Good Health and Well-beingFunctional neuroimagingNeuroplasticityJournal ArticlemedicineHumanslcsh:ScienceNon-U.S. Gov'tStrokeMotor skillAgedNeuronal PlasticityMultidisciplinarymedicine.diagnostic_testbusiness.industryFunctional NeuroimagingResearch Support Non-U.S. Gov'tlcsh:RBrainRecovery of FunctionMiddle Agedmedicine.diseaseMagnetic Resonance ImagingStrokeMotor SkillsPhysical therapy/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beinglcsh:QFemaleFunctional magnetic resonance imagingbusinessResearch ArticlePLOS ONE
researchProduct

Serum surfactant protein D and exhaled nitric oxide as biomarkers of early lung damage in systemic sclerosis

2017

Background Interstitial lung disease (ILD) complicates the course of systemic sclerosis (SSc), representing the main cause of death in these patients. The identification of parameters that can predict the early onset and progression of ILD in SSc represents an unmet need in clinical practice. The study was designed to explore whether the surfactant proteins (SP) A and D may be used as noninvasive tools for the early identification of ILD in SSc. Alveolar exhaled nitric oxide (NO) was investigated as a surrogate marker of distal inflammation. Methods Unselected consecutive subjects newly diagnosed with scleroderma and subjects free of respiratory and systemic diseases were recruited. All pat…

AdultMalemedicine.medical_specialtyBreath TestSettore MED/10 - Malattie Dell'Apparato RespiratorioGastroenterologySclerodermaScleroderma03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineDLCOInternal medicineMedicineHumansRespiratory systemLungScleroderma Systemicbusiness.industryPulmonary surfactant-associated proteinMedicine (all)SystemicInterstitial lung diseaseSurfactant protein DNitric oxideGeneral MedicineBiomarkerrespiratory systemmedicine.diseasePulmonary Surfactant-Associated Protein Dmedicine.anatomical_structure030228 respiratory systemBreath Tests030220 oncology & carcinogenesisLung diseaseExhaled nitric oxideFemalebusinessInterstitialLung Diseases InterstitialBiomarkersHuman
researchProduct

Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma.

2011

Abstract Background There is no consensus about the most effective method for transarterial chemoembolisation of hepatocellular carcinoma. Aim The aim of this phase II trial was to compare the efficacy and toxicity of lipiodol transarterial chemoembolisation with amiodarone in association with pirarubicin or doxorubicin versus lipiodol transarterial chemoembolisation with anthracycline alone in a control group. Methods Patients with unresectable hepatocellular carcinoma and Child-Pugh A/B7 were considered eligible for the trial. transarterial chemoembolisation was repeated every 6 weeks for a maximum of 4 sessions. Results Thirteen patients were randomised in the amiodarone group, and 14 we…

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularAnthracyclinePirarubicinAmiodaroneKaplan-Meier EstimateAmiodaroneGastroenterologyDisease-Free Survivallaw.inventionExcipientsEthiodized OilRandomized controlled triallawInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansChemoembolization TherapeuticAgedHepatologybusiness.industryLiver NeoplasmsGastroenterologyMiddle Agedmedicine.diseaseSurgeryClinical trialTreatment OutcomeDoxorubicinHepatocellular carcinomaLipiodolFemalebusinessmedicine.drugDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency

2015

BackgroundLysosomal acid lipase is an essential lipid-metabolizing enzyme that breaks down endocytosed lipid particles and regulates lipid metabolism. We conducted a phase 3 trial of enzyme-replacement therapy in children and adults with lysosomal acid lipase deficiency, an underappreciated cause of cirrhosis and severe dyslipidemia. MethodsIn this multicenter, randomized, double-blind, placebo-controlled study involving 66 patients, we evaluated the safety and effectiveness of enzyme-replacement therapy with sebelipase alfa (administered intravenously at a dose of 1 mg per kilogram of body weight every other week); the placebo-controlled phase of the study was 20 weeks long and was followe…

AdultMalemedicine.medical_specialtyCirrhosisAdolescentHDLBiopsy[SDV]Life Sciences [q-bio]Lysosomal acid lipase deficiencyGastroenterologyLDLlaw.inventionYoung Adultchemistry.chemical_compoundDouble-Blind MethodRandomized controlled triallawInternal medicinemedicineHumansAdolescent; Adult; Aged; Alanine Transaminase; Biopsy; Child; Child Preschool; Cholesterol HDL; Cholesterol LDL; Double-Blind Method; Dyslipidemias; Female; Humans; Liver; Male; Middle Aged; Sterol Esterase; Wolman Disease; Young AdultChildPreschoolComputingMilieux_MISCELLANEOUSAgedDyslipidemiasbiologyCholesterolbusiness.industryWolman DiseaseAlanine TransaminaseLipid metabolismGeneral MedicineMiddle AgedSterol Esterasemedicine.disease3. Good healthCholesterolEndocrinologyLiverSebelipase alfachemistryAlanine transaminasebiology.proteinFemalebusinessDyslipidemia
researchProduct

Efect of periodontal disease and non surgical periodontal treatment on C-reactive protein. Evaluation of type 1 diabetic patients

2011

Objectives: The purpose of this study was to analyze how anti-infectious periodontal treatment affects C reactive protein (CRP) values in patients with type 1 diabetes, and correlate baseline CRP levels with periodontal disease severity. Study Design: A cohort of fifty three subjects with type 1 diabetes and moderate to severe periodontitis were recruited. Periodontal parameters were measured, and blood samples were obtained to evaluate high-sensitivity C-reactive protein (hs-CRP). Group 1 was treated with scaling, root planning, and systemic administration of doxycycline. Group 2 received only scaling and root planning. Results: Hs-CRP was reduced after periodontal treatment in group 1 (-0…

AdultMalemedicine.medical_specialtyCirurgia dentalDentistrySeverity of Illness IndexGastroenterologylaw.inventionRandomized controlled triallawInternal medicineDiabetes mellitusSeverity of illnessmedicineHumansSingle-Blind MethodPeriodontitisGeneral DentistryDoxycyclinePeriodontitisType 1 diabetesDiabetisbiologybusiness.industryC-reactive protein:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseC-Reactive ProteinDiabetes Mellitus Type 1OtorhinolaryngologyEstomatologiaUNESCO::CIENCIAS MÉDICASCohortbiology.proteinFemaleResearch-ArticleOdontostomatology for the Disabled or Special PatientsSurgerybusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

The eye-tracking computer device for communication in amyotrophic lateral sclerosis

2013

Objective To explore the effectiveness of communication and the variables affecting the eye-tracking computer system (ETCS) utilization in patients with late-stage amyotrophic lateral sclerosis (ALS). Methods We performed a telephone survey on 30 patients with advanced non-demented ALS that were provisioned an ECTS device. Median age at interview was 55 years (IQR = 48–62), with a relatively high education (13 years, IQR = 8–13). A one-off interview was made and answers were later provided with the help of the caregiver. The interview included items about demographic and clinical variables affecting the daily ETCS utilization. Results The median time of ETCS device possession was 15 months …

AdultMalemedicine.medical_specialtyClinical variablesEye MovementsCommunication Aids for DisabledPhysical medicine and rehabilitationmedicineHumansIn patientAmyotrophic lateral sclerosisComputer devicebusiness.industryData CollectionAmyotrophic Lateral SclerosisEye movementHigh educationGeneral MedicineMiddle Agedmedicine.diseaseCaregiversNeurologyMedian timeBrain-Computer InterfacesCommunication DisordersPhysical therapyEye trackingFemaleNeurology (clinical)businessActa Neurologica Scandinavica
researchProduct

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observ…

2018

BACKGROUND: European guidelines recommend intravenous methylprednisolone as first-line treatment for active and severe Graves' orbitopathy; however, it is common for patients to have no response or have relapse after discontinuation of treatment. We aimed to compare the efficacy and safety of add-on mycophenolate to methylprednisolone in comparison with methylprednisolone alone in patients with moderate-to-severe Graves' orbitopathy.METHODS: MINGO was an observer-masked, multicentre, block-randomised, centre-stratified trial done in two centres in Germany and two in Italy. Patients with active moderate-to-severe Graves' orbitopathy were randomly assigned to receive intravenous methylprednis…

AdultMalemedicine.medical_specialtyCombination therapyAdolescentEndocrinology Diabetes and MetabolismPopulationMedizinAnti-Inflammatory Agents030209 endocrinology & metabolismMethylprednisoloneSeverity of Illness IndexMycophenolic acidlaw.inventionGraves' ophthalmopathy03 medical and health sciencesYoung Adult0302 clinical medicineEndocrinologyRandomized controlled trialDouble-Blind MethodlawInternal medicineJournal ArticleInternal MedicinemedicineHumanseducationAdverse effectAgededucation.field_of_studyAntibiotics Antineoplasticbusiness.industryMiddle AgedMycophenolic Acidmedicine.diseaseDiscontinuationGraves OphthalmopathyTreatment OutcomeMethylprednisoloneItaly030221 ophthalmology & optometryDrug Therapy CombinationFemalebusinessmedicine.drugThe lancet. Diabetesendocrinology
researchProduct